Gene · 8880
Papers1,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic profiling of rat gliomas and cardiac schwannomas from life-time radiofrequency radiation exposure study using a targeted next-generation sequencing gene panel. | PLoS One | 2024 | 38232086 | PubTator, text mining | PubMed |
| Identifying BMI-associated genes via a genome-wide multi-omics integrative approach using summary data. | Hum Mol Genet | 2024 | 38215789 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis and experimental validation identified CDCA families as prognostic biomarkers and sensitive indicators for rapamycin treatment of glioma. | PLoS One | 2024 | 38181024 | PubTator, text mining | PubMed |
| Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response. | Nat Commun | 2024 | 38167338 | PubTator, text mining | PubMed |
| hGRAD: A versatile "one-fits-all" system to acutely deplete RNA binding proteins from condensates. | J Cell Biol | 2024 | 38108808 | PubTator, text mining | PubMed |
| Multiple Oligo assisted RNA Pulldown via Hybridization followed by Mass Spectrometry (MORPH-MS) for exploring the RNA-Protein interactions. | RNA Biol | 2024 | 38105541 | PubTator, text mining | PubMed |
| miRNAs as biomarkers of therapeutic response to HER2-targeted treatment in breast cancer: A systematic review. | Biochem Biophys Rep | 2024 | 38088952 | PubTator, text mining | PubMed |
| miRNAs and related genetic biomarkers according to the WHO glioma classification: From diagnosis to future therapeutic targets. | Noncoding RNA Res | 2024 | 38035044 | PubTator, text mining | PubMed |
| Hsa_circ_0050900 affects ferroptosis in intrahepatic cholangiocarcinoma cells by targeting hsa‑miR-605‑3p to regulate SLC3A2. | Oncol Lett | 2024 | 38028176 | PubTator, text mining | PubMed |
| DNA superhelicity. | Nucleic Acids Res | 2024 | 37994702 | PubTator, text mining | PubMed |
| Cuprotosis clusters predict prognosis and immunotherapy response in low-grade glioma. | Apoptosis | 2024 | 37713112 | PubTator, text mining | PubMed |
| A Retrospective Genomic Landscape of 661 Young Adult Glioblastomas Diagnosed Using 2016 WHO Guidelines for Central Nervous System Tumors. | Oncologist | 2024 | 37619245 | PubTator, text mining | PubMed |
| Advances in anti-EV-A71 drug development research. | J Adv Res | 2024 | 37001813 | PubTator, text mining | PubMed |
| Gene signatures associated with prognosis and chemotherapy resistance in glioblastoma treated with temozolomide. | Front Genet | 2023 | 38259614 | PubTator, text mining | PubMed |
| The Repurposing of Cellular Proteins during Enterovirus A71 Infection. | Viruses | 2023 | 38257775 | PubTator, text mining | PubMed |
| Identification of efferocytosis-related subtypes in gliomas and elucidating their characteristics and clinical significance. | Front Cell Dev Biol | 2023 | 38161335 | PubTator, text mining | PubMed |
| The Link of mRNA and rRNA Transcription by PUF60/FIR through TFIIH/P62 as a Novel Therapeutic Target for Cancer. | Int J Mol Sci | 2023 | 38139171 | PubTator, text mining | PubMed |
| The RNA-binding KH-domain in the unique transcription factor of the malaria parasite is responsible for its transcriptional regulatory activity. | PLoS One | 2023 | 38128025 | PubTator, text mining | PubMed |
| "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade. | Acta Neuropathol | 2023 | 38079020 | PubTator, text mining | PubMed |
| Circular RNA CDR1as Mediated by Human Antigen R (HuR) Promotes Gastric Cancer Growth via miR-299-3p/TGIF1 Axis. | Cancers (Basel) | 2023 | 38067260 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8880/papers?page=4